Training on Using ıInsulin in Patients With Type 2 Diabetes

NCT ID: NCT05915338

Last Updated: 2023-06-26

Basic Information

• Recruitment Status: COMPLETED
• Total Enrollment: 84 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2022-10-01
• Study Completion Date: 2023-03-30

Brief Summary

This study was conducted to evaluate the effect of individual insulin use training given to patients with type 2 diabetes using insulin on safe drug administration, pain level and perception of treatment. The study was conducted between October 2022 and March 2023 with a randomized control group.

Detailed Description

Objective: The aim of this study was to examine the effects of individual insulin use training given to patients with Type 2 diabetes on safe drug administration, pain level and treatment perception, and to contribute to both national and international literature.

Method: It was conducted between October 2022 and March 2023 as a randomized controlled study in a pre-test-post-test order to determine the effect of individual insulin use education given to patients with type 2 diabetes on safe drug administration, pain level and treatment perception. The data were collected by the researchers with the descriptive information form of the patients, the Insulin Administration Skill Observation Form, the Visual Analogue Scale and the Insulin Therapy Evaluation Scale.

Data Collection: Face-to-face and individual interviews with patients who applied to the Internal Diseases and Endocrinology Polyclinic and Diabetes Nursing Polyclinics of a state hospital in a city located in the Southeastern Anatolia Region of Turkey, and who were hospitalized in the Internal Diseases, Endocrinology, Physical Therapy and Rehabilitation and Cardiology Services. collected using the method. A pilot study was not conducted before starting the study. Before the study, all patients were informed about the study and their verbal and written consents were obtained.

Conditions

Insulin Dependent Diabetes; Diabetes type2

Study Design

• Observational Model Type: OTHER
• Study Time Perspective: OTHER

Study Groups

Experimental Group

-Pre-test data were obtained by using the descriptive information form, İUBGF, VAS, and HRAS.

The patients were asked to self-administer a dose of insulin that day, and the ability of the patients to administer the insulin dose was recorded in the IUBGF as the 1st follow-up by the researchers. Afterwards, individual insulin use training was given and the "Educational Manual on the Use of Insulin for Individuals with Type 2 Diabetes" was given to the patients and the first follow-up was completed.

-2 weeks later, post-test data were obtained from the patients using IUBGF, VAS, and HRAS. The ability of the patients to administer the insulin dose was recorded in the IUBGF as the second follow-up by the researchers.

After 8 weeks, post-test data were obtained by using IUBGF, VAS, and HRAS as retention tests. The ability of the patients to administer the insulin dose was recorded by the researchers as the 3rd follow-up retention test in IUBGF.

No interventions assigned to this group

Control Group

-Pre-test data were obtained by using the descriptive information form, İUBGF, VAS, and HRAS.

The patients were asked to self-administer a dose of insulin that day, and the ability of the patients to administer the insulin dose was recorded in the IUBGF as the 1st follow-up by the researchers.

-2 weeks later, post-test data were obtained from the patients using IUBGF, VAS, and HRAS. Patients were asked to self-administer a daily dose of insulin. The ability of the patients to administer the insulin dose was recorded in the IUBGF as the second follow-up by the researchers.

After 8 weeks, post-test data were obtained by using IUBGF, VAS, and HRAS as retention tests. Patients were asked to self-administer a daily dose of insulin. The ability of the patients to administer the insulin dose was recorded in IUBGF as the 3rd follow-up retention test by the researchers.

No interventions assigned to this group

Eligibility Criteria

Inclusion Criteria

Patients included in the study;

• 18 years and over Using insulin injections for at least six months or longer
• Meeting the American Diabetes Association (ADA, 2021) diagnostic criteria for Type 2 diabetes
• No communication and mental problems
• Insulin injection made by himself or his family The patients who agreed to participate in the study.

Exclusion Criteria

Patients excluded from the study;

• Self or family member health personnel Those with advanced retinopathy, nephropathy, neuropathy
• Diagnosed with type 1 diabetes
• Pregnant or breastfeeding women
• Patients who participated in another clinical trial concurrently or within 1 month prior to the start of the trial.

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

Inonu University

OTHER

Sponsor Role: lead

Responsible Party

Serap Parlar Kılıç

Professor Doctor

Responsibility Role: PRINCIPAL_INVESTIGATOR

Locations

Şirnak Devlet Hastanesi

Şirnak, Merkez, Turkey (Türkiye)

Countries

Turkey (Türkiye)

References

Ozturk MH, Kerkez M, Kilic SP. The power of insulin education: enhancing pain and treatment perception in adult type 2 diabetes patients. J Diabetes Metab Disord. 2025 Jun 5;24(1):140. doi: 10.1007/s40200-025-01652-2. eCollection 2025 Jun.

Reference Type: DERIVED

PMID: 40485759 (View on PubMed)

Other Identifiers

INONU UNİV

Identifier Type: -

Identifier Source: org_study_id